Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04024436
Title A Study of TAS-120 in Patients With Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

triple-receptor negative breast cancer

Her2-receptor negative breast cancer

Therapies

Fulvestrant + Futibatinib

Futibatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST